Angiotensin converting enzyme inhibitors suppress production of tumor necrosis factor-α in vitro and in vivo
- 1 April 1997
- journal article
- Published by Elsevier in Immunopharmacology
- Vol. 36 (1) , 49-55
- https://doi.org/10.1016/s0162-3109(96)00160-9
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare (06670997)
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 25 references indexed in Scilit:
- Vesnarinone prolongs survival and reduces lethality in a murine model of lethal endotoxemiaLife Sciences, 1994
- Tumor necrosis factor alpha: a key component of the obesity-diabetes linkDiabetes, 1994
- Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.Journal of Clinical Investigation, 1993
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993
- Newer ACE InhibitorsDrugs, 1990
- Cachectin: More Than a Tumor Necrosis FactorNew England Journal of Medicine, 1987
- Cilazapril Prevents Hypertension in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1986
- Antihypertensive Action of a Non-Sulfhydryl Angiotensin Converting Enzyme Inhibitor (CV-3317) in Various Hypertensive ModelsThe Japanese Journal of Pharmacology, 1986
- The effect of SQ14,225 on systolic blood pressure and urinary excretion of vasopressin in the developing spontaneously hypertensive rat.Hypertension, 1979
- Angiotensin converting enzyme inhibition in patients with congestive heart failure.Circulation, 1978